Home Dermatology PDF: Update on Drugs & Devices: May-June 2021
- You cannot add another "PDF: Real-World Efficacy of Azelaic Acid 15% Gel for the Reduction of Inflammatory Lesions of Rosacea" to your cart. View cart
Article
PDF: Update on Drugs & Devices: May-June 2021
$1.99
PDF Download: The update covers: Axatilimab IV injection – SNDX-6352 (Syndax Pharmaceuticals), Binimetinib tablets + encorafenib capsules – Mektovi® + Braftovi® (Pfizer Canada), Encapsulated cell therapy for Fabry disease – SIG-007 (Sigilon Therapeutics) and Oritavancin IV injection – Kimyrsa™ (Melinta Therapeutics).
Related products
-
Article
PDF: Real-World Efficacy of Azelaic Acid 15% Gel for the Reduction of Inflammatory Lesions of Rosacea
$1.99 Add to cart -
Article
PDF: Non-Invasive Gene Expression Testing to Rule Out Melanoma
$1.99 Add to cart -
Article
PDF: Update on Drugs & Devices: September – October 2019
$1.99 Add to cart -
Article
PDF: Hydrogen Peroxide Topical Solution, 40% for the Treatment of Seborrheic Keratoses
$1.99 Add to cart
